Clinical Liver Disease
© The American Association for the Study of Liver Diseases
Recently Published Issues
Current Issue:October 2015
Volume 6, Issue 4
Special Issue: New Treatments for CLD, Ethics and ...
Volume 6, Issue 3
Special Issue: Liver and the Microbiome, Non-Viral...
Volume 6, Issue 2
Special Issue: Editorial, Palliative Care & Non-Vi...
Volume 6, Issue 1
Special Issue: The Future in Liver Medicine & Pall...
Volume 5, Issue 6
Special Issue: The Future in Liver Medicine, Liver...
Overview of Palliative Care and Hospice Services
Sara E. Wordingham, M.D. and Keith M. Swetz, M.D., M.A.
Issues in the End-Stage Liver Disease Patient for Which Palliative Care Could Be Helpful
Paula Cox-North, Ph.D., A.R.N.P.
Working With Palliative Care Services
Amanda J. Brisebois M.Sc., M.D., and Puneeta Tandon M.D.
Overall Health-Related Quality of Life in Patients With End-Stage Liver Disease
Zobair Younossi, M.D., M.P.H., and Linda Henry Ph.D.
A ‘‘Good Death’’ With Irreversible Liver Disease: Talking With Patients and Families About Deteriorating Health and Dying
Kirsty Boyd, M.B.Ch.B.(Hon.), F.R.C.P. (Edin.), M.Med.Sci., Barbara Kimbell, Ph.D., Scott Murray, M.B.Ch.B., D.C.H., M.R.C.G.P., M.D., F.R.C.G.P., F.R.C.P.Ed., John Iredale D.M., F.R.C.P., F.Med.Sci., F.R.S.E.
Palliative Care for Patients with End-Stage Liver Disease: An Overview
Mina O. Rakoski, M.D., M.Sc. and Michael L. Volk, M.D., M.Sc., AGAF
Palliative Care for Patients With End-Stage Liver Disease: The Role of the Liver Team
Sean G. Kelly, M.D. and John P. Rice, M.D.
Is Palliative Care Appropriate in the Liver Transplant Candidate?
Rohit Pai M.D., Constantine J. Karvellas M.D., S.M.
Liver and the Microbiome
Guest Edited by Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI
The gut microbiome in NAFLD and ALD
Irina A. Kirpich Ph.D, Dipendra Parajuli M.D.and Craig J. McClain M.D.
Host-Microbiome Interactions in Health and Disease
Liam O’Mahony, PhD
Microbiome-Immune Interactions and Liver Disease
James H. Tabibian MD, PhD, Cyril Varghese MD, Steven P. O’Hara PhD, and Nicholas F. LaRusso MD
The Gut Microbiome: What Do We Know?
Francisco Guarner, MD, PhD
The Metabolic Role of the Microbiota
Wiley Barton B.Sc. Fergus Shanahan MD, Paul D. Cotter PhD, Orla O’Sullivan PhD
Is the Gut Microbiota Disturbed in Chronic Liver Disease?
Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI
Microbiome and Complications of Liver Disease
Jasmohan S. Bajaj, MD, MS, FACG, AGAF
Access CLD on the go.
Listen to the author interviews and readings of the full articles by subscribing to the iTunes podcast.
New Editorial Series: In My Opinion
Hepatitis C Treatment:
NEW in Non-Cirrhotic Portal Hypertension:
Guest Edited by Theo Heller, MD, Ohad Etzion, MD, and Christopher Koh, MD
Noncirrhotic portal hypertension: An overview
Theo Heller, MD, Ohad Etzion, MD, and Christopher Koh, MD, Elliot Levy, MD
Non-viral Liver Infections
Guest Edited by Emily A. Blumberg, M.D.NEW!
Schistosomiasis: Clinical management of liver disease
Marta Guimarães Cavalcanti M.D., Ph.D., João Marcello de Araujo-Neto M.D. and José Mauro Peralta M.D., Ph.D.
Herpes virus infections
Daniel Mueller M.D., and Heather Clauss M.D.
Amebic Liver Abscess
Judith A. Anesi M.D., and Stephen Gluckman M.D.
Recognizing Clonorchiasis: A Foodborne Illness Leading to Significant Hepatobiliary Disease
Charitha Gowda, M.D., M.P.H.
Oliver A. Cornely M.D., Christopher Bangard M.D., and Natalie I. Jaspers M.D.
Pyogenic Liver Abscess
Sarah Longworth M.D. and Jennifer Han M.D., M.S.C.E.
The Future in Liver Medicine
Guest Edited by Meena Bansal, MD
The extinction of chronic viral hepatitis?
Sonal Kumar M.D. and Ira M. Jacobson M.D.
Liver Fibrosis: Therapeutic Armory 40 Years On
John P. Iredale, FRCP, F Med Sci, FRSE, and Antonella Pellicoro, PhD
Histologic and Noninvasive Estimates of Liver Fibrosis
Pierre Bedossa, M.D., Ph.D., Keyur Patel, M.D., and Laurent Castera, M.D., Ph.D.
The Future of Hepatology: Embrace Change
Scott L. Friedman MD and Yael L. Friedman MA
Training the Next Generation of Hepatologist: What Will They Need to Know?
Dina L. Halegoua-De Marzio MD, and Steven K. Herrine MD
Personalized Management of Hepatocellular Carcinoma Based on Molecular Information: Future Prospects
Nicolas Goossens, MD, MSc Yujin Hoshida, MD, PhD
Increasing Impact of Drug-Induced Liver Injury
Paul H. Hayashi, MD, MPH and Naga P. Chalasani MD
Future Watch: Evolving Trends in the Management of Nonalcoholic Steatohepatitis
Arun J. Sanyal, MBBS, MD